breast-cancer-2017-keynote

2 / 6

Volume 2, Issue 3 (Suppl) Breast Can Curr Res, an open access journal
ISSN: 2572-4118 Breast Cancer 2017
June 15-17, 2017
Page 30
Notes:
conferenceseries.com
June 15-17, 2017 London, UK
5th World Congress on
Breast Cancer
Sarah Spiegel, Breast Can Curr Res 2017, 2:3(Suppl)
DOI: 10.4172/2572-4118-C1-004
Role of sphingosine-1-phosphate in estrogen receptor signaling in breast cancer
Breast cancer remains the most common malignant disease in women. The estrogen receptor-α (ERα) and its ligand
17β-estradiol (E2) play important roles in breast cancer. E2 elicits cellular effects by binding to ERα in the cytosol followed by
receptor dimerization and translocation to the nucleus where it regulates gene expression by binding to ERE response elements.
However, it has become apparent that E2 also exerts rapid non-genomic effects through membrane-associated receptors. There
is emerging evidence that this induces formation of the bioactive sphingolipid metabolite sphingosine-1-phosphate (S1P). S1P
in turn regulates many processes important in breast cancer progression and metastasis. One of the enzymes that produce
S1P, sphingosine kinase 1 (SphK1), is upregulated in breast cancer and its expression has been correlated with poor prognosis.
This lecture will focus on the role of the SphK/S1P axis in estrogen signaling and breast cancer progression. I will also discuss
new data showing that ERα36 is the E2 membrane receptor required for E2-mediated SphK1 activation and rapid secretion of
S1P, which regulates some of the non-genomic effects of E2. Our data also suggests that targeting SphK1/S1P signaling may
potentially be a new therapeutic option for treatment of triple negative breast cancer.
Biography
Sarah Spiegel is the Chair Person of the Department of Biochemistry and Molecular Biology at Virginial Commonwealth University School of Medicine and directs
the cancer cell signaling program at the MCC. Her research is focused on sphingosine-1-phosphate (S1P), whose functions as a pleiotropic signaling lipid were
discovered in her lab that opened a new areas of research focused on this bioactive sphingolipid metabolite. As a result of her work, it is now recognized that S1P
regulates numerous biological processes and is critical for health and diseases. She has published more than 300 papers and received many awards for her work.
Sarah Spiegel
Virginia Commonwealth University, USA